Here we also identified 4 candidate CNVs disrupting 5 genes associated with several carcinomas and involved in interesting biological pathways namely BCL3, COL7A1, RNF5, CEP290 and TMTC3. The screening of these CNVs could be considered particularly in breast cancer patients’ non-carriers of pathogenic point mutations. The gene discussed is BCL3; the disease is breast carcinoma.